Basic information Description Safety Related Supplier
ChemicalBook >  Product Catalog >  API >  Inhibitors >  Tenofovir Alafenamide

Tenofovir Alafenamide

Basic information Description Safety Related Supplier
Tenofovir Alafenamide Basic information
Tenofovir Alafenamide Chemical Properties
  • Boiling point:640.4±65.0 °C(Predicted)
  • Density 1.39±0.1 g/cm3(Predicted)
  • storage temp. Keep in dark place,Sealed in dry,2-8°C
  • pka4.21±0.10(Predicted)
Tenofovir Alafenamide Usage And Synthesis
  • DescriptionTenofovir Alafenamide (GS-7340) is a prodrug of tenofovir, which is a reverse transcriptase inhibitor, used to treat HIV and Hepatitis B.-Reverse Transcriptase inhibitor. It was developed by Gilead Sciences. Compared to tenofovir disoproxil fumarate, tenofovir alafenamide has a greater antiviral activity and better distribution into lymphoid tissues.
  • DescriptionTenofovir alafenamide fumarate is an oral phosphonoamidate prodrug of the reverse transcriptase inhibitor tenofovir. It was approved by the USFDA for the treatment of chronic hepatitis B virus infection with compensated liver disease. Tenofovir alafenamide fumarate was discovered and developed by Gilead as a potentially safer form of the previously approved tenofovir disoproxil fumarate (Viread).
  • DefinitionChEBI: An L-alanine derivative that is isopropyl L-alaninate in which one of the amino hydrogens is replaced by an (S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)( henoxy)phosphoryl group. A prodrug for tenofovir, it is used (as the fumarate salt) in combination therapy for the treatment of HIV-1 infection.
  • Chemical SynthesisA multikilogram synthesis of tenofovir alafenamide fumarate was described in a Gilead patent. Additional process improvements on specific steps of the Gilead process have been reported on 100 g scale, and these will be noted throughout the description of the synthesis. The synthesis was initiated with the alkylation of adenine (72) with (R)-propylene carbonate (73) to give hydroxypropyl adenine 74 in 75% yield. It should be noted that sodium hydroxide can be replaced by potassium bases with increased yields on 100 g scale.27 Alkylation of 74 with diethyl p-toluenesulfonyloxymethylphosphonate (75) gave intermediate 76, which was not isolated. Hydrolysis of the phosphonate esters with trimethylsilyl bromide followed by recrystallization from water gave phosphonic acid 77 in 50% yield. Interestingly, replacing Mg(Ot-Bu)2 with PhMgCl/t-BuOH led to improved yields for the alkylation step (74 → 76) on a 100 g scale. Additionally, the authors note that conditions for hydrolyzing the phosphonate ester can be modified using HCl or HBr for improved yields on smaller scale. Dicyclohexylcarbodiimide (DCC) coupling of 77 with phenol produced phosphonate 78 in 51% yield. This step was also reported to proceed in higher yield on smaller scale by changing the solvent to cyclopentylmethyl ether. Monophosphonate ester 78 was treated with thionyl chloride followed by L-alanine isopropyl ester (79) and triethylamine to give tenofovir alafenamide rac-80 as a mixture of phosphonate diastereomers in 47% yield. The diastereomers were separated using simulated moving bed chromatography to give the desired diastereomer ent-80 in 47% yield and 99% diastereomeric purity. The diastereomers could also be separated using a crystallization-induced dynamic resolution of rac-80. Tenofovir alafenamide fumarate (VI) was prepared from ent-80 and fumaric acid in 83% yield.

Tenofovir Alafenamide(379270-37-8)Related Product Information
Tenofovir AlafenamideSupplierMore
  • Company Name:Nanjing heryon Biotech Co., Ltd. Gold
  • Tel:18652960783
  • Company Name:Nanjing Gold Pharmaceutical Technology Co. Ltd. Gold
  • Tel:15905158493
  • Company Name:Huangshi Fuertai Pharmaceutical Tech Co., Ltd. Gold
  • Tel:13995956430 0714-3293168-6021
  • Company Name:Senova Technology Co., Ltd. Gold
  • Tel:86-13723419324
  • Tel:13656237714
  • QQ374216861;